Pharmacologically regulated in vivo selection in a large animal

Blood

Volumn 100, Issue 6, 2002, Pages 2026-2031

  Neff, Tobias ^a,b,c,d,e,f   Horn, Peter A ^a,b,c,d,e,f   Valli, Victor E ^a,b,c,d,e,f   Gown, Allen M ^a,b,c,d,e,f   Wardwell, Scott ^a,b,c,d,e,f   Wood, Brent L ^a,b,c,d,e,f   Von Kalle, Christof ^a,b,c,d,e,f   Schmidt, Manfred ^a,b,c,d,e,f   Peterson, Laura J ^a,b,c,d,e,f   Morris, Julia C ^a,b,c,d,e,f   Richard, Robert E ^a,b,c,d,e,f   Clackson, Tim ^a,b,c,d,e,f   Kiem, Hans Peter ^a,b,c,d,e,f   Anthony Blau, C ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d PHENOPATH LABORATORIES   (United States)

^e ARIAD PHARMACEUTICALS INC   (United States)

^f UNIVERSITY OF FREIBURG   (Germany)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AP 20187; CD34 ANTIGEN; DIMER; GENE PRODUCT; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL GROWTH; CONTROLLED STUDY; DNA MODIFICATION; DOG; DRUG INDUCED DISEASE; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

EID: 0037105534     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0792     Document Type: Article

References (35)

1. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
2. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
3. In vivo selection of retrovirally transduced hematopoietic stem cells
4. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1
5. Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection
6. Canine model for gene therapy: Inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors
7. The common marmoset as a target preclinical primate model for cytokine and gene therapy studies
8. Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma-chain and multidrug resistance (MDR1) transgenes in canine bone marrow
9. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation
10. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients
11. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy
12. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy
13. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human longterm repopulating hematopoietic stem cells
14. The hematological effects of folate analogs: Implications for using the dihydrofolate reductase gene for in vivo selection
15. Cytokine prestimulation as a gene therapy strategy: Implications for using the MDR1 gene as a dominant selectable marker
16. A proliferation switch for genetically modified cells
17. Pharmacologically regulated cell therapy
18. Targeted expansion of genetically modified bone marrow cells
19. Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization
20. Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells
21. In vivo selection using a cell-growth switch
22. Bone-marrow transplantation (first of two parts)
23. Bone-marrow transplantation (second of two parts)
24. Gene therapy and bone marrow transplantation
25. Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors
26. The use of granulocyte colonystimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs
27. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples
28. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human betaglobin
29. Correction of sickle cell disease in transgenic mouse models by gene therapy
30. Functional requirements for phenotypic correction of murine beta-thalassemia: Implications for human gene therapy
31. Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers
32. Control of myoblast proliferation with a synthetic ligand
33. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
34. Embryonic stem cell lines derived from human blastocysts
35. Toward regenerative medicine